Search Within

Wolfgang Andreas Weber

Formats
  1. Journal Article (114)
  2. Meeting Abstract (55)
  3. Book Section (2)
  4. Conference Paper (2)
Groups
  1. Molecular Imaging and Therapy Service (173)
  2. Radiology, Department of (173)
  3. Sloan Kettering Institute Postdocs (88)
  4. GSK Faculty (66)
  5. Radiochemistry and Imaging Sciences Service (61)
  6. Medical Physics (47)

More Groups

People
  1. Jason Lewis (30)
  2. Neeta Pandit-Taskar (23)
  3. Serge Lyashchenko (23)
  4. Thomas Reiner (23)
  5. Joseph O'Donoghue (21)
  6. Hanwen Zhang (18)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2021 (1)
  4. 2020 (5)
  5. 2019 (16)
  6. 2018 (23)

More Years

Publications
  1. Journal of Nuclear Medicine (65)
  2. European Journal of Nuclear Medicine and Molecular Imaging (20)
  3. Molecular Imaging and Biology (6)
  4. Journal of Clinical Oncology (5)
  5. Strahlentherapie und Onkologie (5)
  6. Clinical Cancer Research (4)

More Publications

Publishers
  1. Society of Nuclear Medicine (65)
  2. Springer (34)
  3. Elsevier Inc. (10)
  4. American Association for Cancer Research (9)
  5. Springer Verlag (6)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (173)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dual-modality imaging of GRP receptor-expressing prostate cancer with new bombesin antagonist
    Meeting Abstract

    Zhang, H.; Desai, P.; Koike, Y.; Carlin, S.; Tandon, N.; Touijer, K.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of FDG-PET/CT with contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients: A retrospective analysis
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M.; Ulaner, G.; Mcarthur, H.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • How does the number of lesions analyzed impact response assessment with PERCIST in breast cancer?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M.; Ulaner, G.; Dickler, M.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Comparison of SUVmax and SUVpeak for response assessment in stage 4 non-small cell lung cancer (NSCLC) by FDG PET/CT
    Meeting Abstract

    Ong, L.; Rager, O.; Lohrmann, C.; Riedl, C.; Pinker, K.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Feasibility of intraoperative fluorescence imaging of squamous cell carcinoma of the oral cavity using an optical PARP1 inhibitor
    Meeting Abstract

    Kossatz, S.; Irwin, C.; Leigh, S.; Wang, D. N.; Liu, J.; Weber, W.; Reiner, T.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • (18)F-FDG-PET is an early predictor of overall survival in patients with suspected atypical parkinsonian syndromes
    Meeting Abstract

    Hellwig, S.; Frings, L.; Amtage, F.; Buchert, R.; Spehl, T.; Rijntjes, M.; Weiller, C.; Weber, W.; Vach, W.; Meyer, P.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Quantification of PSMA expression in primary human and xenograft tumors using radioligand binding and digital autoradiograpy
    Meeting Abstract

    Carlin, S.; Zhang, H.; Tandon, N.; Desai, P.; Gandhi, A.; Weber, W.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • Wholebody clearance of three (89)Zr labeled antibodies: Differences between PET based and whole body probe based clearance
    Meeting Abstract

    Beylergil, V.; Pandit-Taskar, N.; Larson, S.; Morris, M.; Danila, D. C.; Bander, N.; Fine, B.; Carrasquillo, J.; Weber, W.; O'Donoghue, J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • FDG-PET/CT versus contrast enhanced CT for prediction of progression-free and disease-specific survival in stage IV breast cancer patients
    Meeting Abstract

    Riedl, C.; Pinker, K.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Mcarthur, H. L.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Is response classification with PERCIST in stage IV breast cancer influenced by the number of lesions assessed?
    Meeting Abstract

    Pinker, K.; Riedl, C.; Ong, L.; Jochelson, M. S.; Ulaner, G.; Dickler, M. N.; Weber, W.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save